Making a Difference: Patient-Centered Ulcerative Colitis Care in the Era of JAK Inhibitors and S1P Modulators
Guest: Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
\n\n Guest: Sophie M. Balzora, MD
\n\n Guest: Latonia Ward, M.Min
\n\n\n \n
The goal of this program is to improve the overall management of patients with ulcerative colitis (UC). Specifically, we aim to improve clinician knowledge and competence with respect to the novel mechanisms of action of sphingosine-1-phosphate receptor (S1P) modulators and Janus kinase (JAK) inhibitors and their respective roles in the overall treatment paradigm of UC. We also aim to improve patient-centered approaches to the management of UC with a particular focus on underserved communities and Black, Indigenous, and people of color (BIPOC). To bolster our commitment to these patient populations, Boston University Chobanian & Avedisian School of Medicine partnered with Color of Crohn\u2019s & Chronic Illness (COCCI) for this initiative.
Endorsed by the AGA Institute